期刊文献+

术后预防性肝动脉化疗栓塞对合并微血管侵犯肝细胞癌患者早期复发的影响 被引量:11

Postoperative prophylactic transcatheter arterial chemoembolization on early recurrence in patients with hepatocellular carcinoma with microvascular invasion
原文传递
导出
摘要 目的比较术后预防性肝动脉化疗栓塞(TACE)对合并微血管癌栓肝癌患者早期复发的影响。方法回顾性分析2012年1月至2013年12月广西医科大学附属肿瘤医院收治的接受根治性肝切除治疗的肝细胞癌患者资料,其中合并微血管侵犯且符合入组条件的患者127例。根据术后是否行预防性TACE把患者分为两组,单纯手术组(I组)86例和手术联合预防性TACE组(Ⅱ组)41例。结果经PSM法均衡组问协变量后,共有39对匹配成功,I组和Ⅱ组患者4、8、12个月累积无复发生存率分别为68.3%、57.8%、41.4%和89.7%、76.1%、62.8%,组问比较差异有统计学意义(X2=4.247,P〈0.05)。结论对于合并微血管侵犯的肝癌患者,在根治性切除术后予以预防性TACE可有效延缓早期复发。 Objective To study the effects of postoperative prophylactic transcatheter arterial che- moembolization (TACE) on early recurrence ( ≤1 year) in patients with hepatocellular carcinoma (HCC) with microvascular invasion. Methods We collected the clinical data of HCC patients treated with radical hepateetomy from Cancer Hospital of Guangxi Medical University between January 2012 and December 2013, and 127 eligible cases with microvascular invasion were reviewed. According to the treatment with or without TACE, the patients were divided into hepateetomy alone group (group Ⅰ , n = 86) and combined with TACE group (group Ⅱ , n = 41 ). The PSM (Propensity Score Matching) of SPSS software was used to reduce con- founding bias between the two groups, and the disease free survival rates were compared between the matched data. Results Thirty-nine pairs were matched with PSM for balancing eovariates in the two groups. The relapse-free survival rates of 4, 8 and 12-month were all significantly higher in the group Ⅱ (89. 7% , 76. 1% , 62.8% ) than that in group I (68.3%, 57.8% , 41.4% ). There were significantly statistical differences ( X2 =4.247, P 〈0.05). Cox regression analysis revealed serum AST level was an inde- pendent prognostic factor associated with poor early recurrence. Conclusion Prophylactic TACE after radical resection might have benefits in delaying early-onset recurrence for HCC patients with microvascular invasion.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2016年第9期607-610,共4页 Chinese Journal of Hepatobiliary Surgery
基金 国家自然科学基金(81260331) 广西区域性高发肿瘤早期防治研究教育部重点实验室自主研究课题(GKE2015-ZZ05)
关键词 肝细胞癌 预防性TACE 早期复发 微血管侵犯 Hepatocellular carcinoma Prophylactic transcatheter arterial chemoembolization Early recurrence Microvascular invasion
  • 相关文献

参考文献7

二级参考文献82

  • 1童颖,杨甲梅.原发性肝癌的门静脉化疗进展[J].中国实用外科杂志,2005,25(2):116-118. 被引量:13
  • 2周信达,汤钊猷,余业勤,杨秉辉,马曾辰,陆继珍,林芷英,叶胜龙,吴志全.肝癌多模式治疗的远期疗效[J].中华外科杂志,1996,34(9):518-521. 被引量:34
  • 3吴孟超.应重视小肝癌的诊断与治疗[J].中华医学杂志,2007,87(30):2089-2091. 被引量:11
  • 4Yamada K, Izaki K, Sugimoto K, et al. Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys, 2003,57:113-119.
  • 5Cedrone A, Rapaccini GL, Pompili M,et al. Portal vein thrombosis complicating hepatocellular carcinoma. Value of ultrasound-guided fine-needle biopsy of the thrombus in the therapeutic management.Liver, 1996,16:94-98.
  • 6Fong Y, Sun RL, Jarnagin W, et al. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg, 1999,229:790-799.
  • 7Giannelli G, Pierri F, Trerotoli P, et al. Occurrence of portal vein tumor thrombus in hepatocellular carcinoma affects prognosis and survival. A retrospective clinical study of 150 cases. Hepatol Res,2002,24:50-59.
  • 8Ohkubo T, Yamamoto J, Sugawara Y, et al. Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosis. J Am Coll Surg, 2000, 191:657-660.
  • 9Kumada K,Ozawa K,Okamoto R, et al. Hepatic resection for advanced hepatocellular carcinoma with removal of portal vein tumor thrombi. Surgery, 1990,108:821-827.
  • 10Yamaoka Y,Kumada K,Ino K, et al. Liver resection for hepatocellular carcinoma (HCC) with direct removal of tumor thrombi in the main portal vein. World J Surg, 1992,16 : 1172 - 1177.

共引文献1231

同被引文献115

引证文献11

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部